Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
CDC advisory panel delays vote on hepatitis B vaccines after unruly meeting- UK to hold fresh pork, other affected Spanish products at border amid African swine fever outbreak
- The Rhythms of the Street: Shipping's Tune in the Economy's Symphony
- Everyone knows F1 is for the girls. I wandered into the Las Vegas desert to find out why.
- Why the weirdest sea level changes on Earth are happening off the coast of Japan
- Remain Fit and Sound with These Exercise Fundamentals
- Tire Brands for Senior Drivers: Guaranteeing Security and Solace
- ADHD drugs work, but not the way experts thought
- WHO suspends medical evacuations from Gaza following death of contractor in 'security incident'
